Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kessler

Showing results (451-460 of 467) with videos related to

Pageof 47
Sort By:
Genome Biology|June 4, 2019
A genomic atlas of systemic interindividual epigenetic variation in humansChathura J Gunasekara, C Anthony Scott, Eleonora Laritsky, et al.
Genome Biology|June 12, 2015
Independent genomewide screens identify the tumor suppressor VTRNA2-1 as a human epiallele responsive to periconceptional environmentMatt J Silver, Noah J Kessler, Branwen J Hennig, et al.
Applied Optics|March 13, 2013
Improving the performance of high-laser-damage-threshold, multilayer dielectric pulse-compression gratings through low-temperature chemical cleaningHeather P Howard, Anthony F Aiello, Justin G Dressler, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2001
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: lead optimization affording selective, orally bioavailable compounds with potent anti-HIV activityJ J Hale, R J Budhu, E B Holson, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: structure-activity relationships for substituted 2-Aryl-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-(piperidin-1-yl)butanesP E Finke, L C Meurer, B Oates, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2001
Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infectionD Kim, L Wang, C G Caldwell, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2001
Discovery of human CCR5 antagonists containing hydantoins for the treatment of HIV-1 infectionD Kim, L Wang, C G Caldwell, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Antagonists of the human CCR5 receptor as anti-HIV-1 agents. part 1: discovery and initial structure-activity relationships for 1 -amino-2-phenyl-4-(piperidin-1-yl)butanesC P Dorn, P E Finke, B Oates, et al.
Genome Biology|January 10, 2018
Epigenetic supersimilarity of monozygotic twin pairsTimothy E Van Baak, Cristian Coarfa, Pierre-Antoine Dugué, et al.
Nature Communications|August 25, 2023
DNA methylation at the suppressor of cytokine signaling 3 (SOCS3) gene influences height in childhoodPrachand Issarapu, Manisha Arumalla, Hannah R Elliott, et al.
Pageof 47

Showing results (451-460 of 467) with videos related to

Sort By:
Pageof 47
Genome Biology|June 4, 2019
A genomic atlas of systemic interindividual epigenetic variation in humansChathura J Gunasekara, C Anthony Scott, Eleonora Laritsky, et al.
Genome Biology|June 12, 2015
Independent genomewide screens identify the tumor suppressor VTRNA2-1 as a human epiallele responsive to periconceptional environmentMatt J Silver, Noah J Kessler, Branwen J Hennig, et al.
Applied Optics|March 13, 2013
Improving the performance of high-laser-damage-threshold, multilayer dielectric pulse-compression gratings through low-temperature chemical cleaningHeather P Howard, Anthony F Aiello, Justin G Dressler, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2001
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: lead optimization affording selective, orally bioavailable compounds with potent anti-HIV activityJ J Hale, R J Budhu, E B Holson, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: structure-activity relationships for substituted 2-Aryl-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-(piperidin-1-yl)butanesP E Finke, L C Meurer, B Oates, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2001
Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infectionD Kim, L Wang, C G Caldwell, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2001
Discovery of human CCR5 antagonists containing hydantoins for the treatment of HIV-1 infectionD Kim, L Wang, C G Caldwell, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Antagonists of the human CCR5 receptor as anti-HIV-1 agents. part 1: discovery and initial structure-activity relationships for 1 -amino-2-phenyl-4-(piperidin-1-yl)butanesC P Dorn, P E Finke, B Oates, et al.
Genome Biology|January 10, 2018
Epigenetic supersimilarity of monozygotic twin pairsTimothy E Van Baak, Cristian Coarfa, Pierre-Antoine Dugué, et al.
Nature Communications|August 25, 2023
DNA methylation at the suppressor of cytokine signaling 3 (SOCS3) gene influences height in childhoodPrachand Issarapu, Manisha Arumalla, Hannah R Elliott, et al.
Pageof 47